False-negative hepatitis B virus (HBV) surface antigen in a vaccinated dialysis patient with a high level of HBV DNA in the United States

Matthew C. Foy; Chloe L. Thio; Hyon S. Hwang; Melissa Saulynas; James P. Hamilton; Derek M. Fine; Mohamed G. Atta

doi:10.1128/CVI.05696-11

False-negative hepatitis B virus (HBV) surface antigen in a vaccinated dialysis patient with a high level of HBV DNA in the United States

Matthew C. Foy, Chloe L. Thio, Hyon S. Hwang, Melissa Saulynas, James P. Hamilton, Derek M. Fine, Mohamed G. Atta

School of Medicine

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Abstract

Screening with hepatitis B surface antigen (HBsAg) is highly recommended for at-risk individuals. Mutations in the HBsAg can result in an inability to detect the virus during routine screening. We describe a hemodialysis patient found to have high levels of hepatitis B virus (HBV) DNA and HBV antibody but negative HBsAg on two routine assays.

Original language	English (US)
Pages (from-to)	820-822
Number of pages	3
Journal	Clinical and Vaccine Immunology
Volume	19
Issue number	5
DOIs	https://doi.org/10.1128/CVI.05696-11
State	Published - May 2012

ASJC Scopus subject areas

Immunology and Allergy
Immunology
Clinical Biochemistry
Microbiology (medical)

Access to Document

10.1128/CVI.05696-11

Cite this

@article{889e4cb9ad3c46dd8f74c23d76d21f52,

title = "False-negative hepatitis B virus (HBV) surface antigen in a vaccinated dialysis patient with a high level of HBV DNA in the United States",

abstract = "Screening with hepatitis B surface antigen (HBsAg) is highly recommended for at-risk individuals. Mutations in the HBsAg can result in an inability to detect the virus during routine screening. We describe a hemodialysis patient found to have high levels of hepatitis B virus (HBV) DNA and HBV antibody but negative HBsAg on two routine assays.",

author = "Foy, {Matthew C.} and Thio, {Chloe L.} and Hwang, {Hyon S.} and Melissa Saulynas and Hamilton, {James P.} and Fine, {Derek M.} and Atta, {Mohamed G.}",

year = "2012",

month = may,

doi = "10.1128/CVI.05696-11",

language = "English (US)",

volume = "19",

pages = "820--822",

journal = "Clinical and Vaccine Immunology",

issn = "1556-6811",

publisher = "American Society for Microbiology",

number = "5",

}

TY - JOUR

T1 - False-negative hepatitis B virus (HBV) surface antigen in a vaccinated dialysis patient with a high level of HBV DNA in the United States

AU - Foy, Matthew C.

AU - Thio, Chloe L.

AU - Hwang, Hyon S.

AU - Saulynas, Melissa

AU - Hamilton, James P.

AU - Fine, Derek M.

AU - Atta, Mohamed G.

PY - 2012/5

Y1 - 2012/5

N2 - Screening with hepatitis B surface antigen (HBsAg) is highly recommended for at-risk individuals. Mutations in the HBsAg can result in an inability to detect the virus during routine screening. We describe a hemodialysis patient found to have high levels of hepatitis B virus (HBV) DNA and HBV antibody but negative HBsAg on two routine assays.

AB - Screening with hepatitis B surface antigen (HBsAg) is highly recommended for at-risk individuals. Mutations in the HBsAg can result in an inability to detect the virus during routine screening. We describe a hemodialysis patient found to have high levels of hepatitis B virus (HBV) DNA and HBV antibody but negative HBsAg on two routine assays.

UR - http://www.scopus.com/inward/record.url?scp=84860345110&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860345110&partnerID=8YFLogxK

U2 - 10.1128/CVI.05696-11

DO - 10.1128/CVI.05696-11

M3 - Article

C2 - 22441395

AN - SCOPUS:84860345110

SN - 1556-6811

VL - 19

SP - 820

EP - 822

JO - Clinical and Vaccine Immunology

JF - Clinical and Vaccine Immunology

IS - 5

ER -

False-negative hepatitis B virus (HBV) surface antigen in a vaccinated dialysis patient with a high level of HBV DNA in the United States

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this